#32 – Steve Reed, Co-Founder & Chief Executive Officer Of HDT Bio
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Steve Reed, Co-Founder & Chief Executive Officer Of HDT Bio
What you'll get out of this episode:
- Reed shares his 40-year journey in microbiology and immunology.
- Discussion on HDT Bio's approach to vaccine development for infectious diseases and cancer.
- Insight into the Amplify vaccine platform and its impact on global health.
- Reed's perspective on vaccine accessibility and affordability.
- Preview of HDT Bio's upcoming projects in oncology.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/steven-reed-b23b159b/
Company LinkedIn: https://www.linkedin.com/company/hdt-bio/
Website: https://www.hdt.bio/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/